NEWS

New Study Provides Evidence Supporting the Use of Cannabinoids to Treat Prostate Cancer

Cannabinoids have demonstrated anti-carcinogenic properties in a variety of malignancies, including in prostate cancer”, states researchers. In the present study, they “explored the anti-cancer effects of the synthetic cannabinoid WIN 55,212-2 (WIN) in prostate cancer.”

For the study, “Established prostate cancer cells (PC3, DU145, LNCaP) were treated with varying concentrations of WIN”, and “Cell proliferation was determined by the MTS assay.” The anti-migration and anti-invasive potential of WIN “was examined by the wound healing assay and the matrigel invasion assay.” Cell cycle analysis was performed by flow cytometry, and mechanistic studies were performed by Western blot.

Animals were randomised into two groups: saline control and WIN (5 mg/kg), delivered by intraperitoneal injection three times per week for 3 weeks.

“WIN significantly reduced prostate cancer cell proliferation, migration, invasion, induced apoptosis, and arrested cells in Go/G1 phase in a dose-dependent manner”, claim researchers.

They conclude; “The following study provides evidence supporting the use of WIN as a novel therapeutic for prostate cancer.”

Source: https://thejointblog.com/new-study-provides-evidence-supporting-the-use-of-cannabinoids-to-treat-prostate-cancer

Share:

MORE POSTS

Cilo Cybin Investor update #1

NEWS UPDATE FROM THE DESK OF THE CEO – NOVEMBER 2021 UPDATE ON NEW IPO DEVELOPMENTS going public. During an exclusive interview with Bloomberg Media

Cilo Cybin CBD Vape range

Cilo Cybin Product launch

NEWS UPDATE FROM THE DESK OF THE CEO – NOVEMBER 2021 Taking Cilo Cybin products, devices, and services to market – end November 2021 Excellent

Cannabis Licenses and Certification

In the June 2020 issue of Landscape SA, an article entitled Medicinal Cannabis Licensing was featured. However, the current cannabis industry and regulatory challenges have

Cannabis Dosing and Oils

It is easy to experience medical benefits from cannabis, for example a puff or two of tetrahydrocannabinol (THC) and/or cannabidiol (CBD) can do the trick

Cannabis: Good Manufacturing Practice

Cilo Cybin Pharmaceutical recently obtained its written confirmation certificate from the South African Health Products Regulatory Authority (SAHPRA) for the standards of Good Manufacturing Practice

Before the name Cilo Cybin was born, I was deciding on the services and products I wanted to bring to the world. To me this sounded like ‘MAGIC’ at the time. I came across a substance named ‘Psilocybin’ the active ingredient in certain mushrooms that resembles & kindles a ‘Magical’ experience when ingested.

Cilo Cybin aims to ignite and improve the lives of our customers through a wide range of products and services that, hopefully, one day will be considered ‘MAGIC’.

Visit Us

SOCIAL LINKS

OPENING HOURS

LICENCES

Verify Cannabis Licence

Join The club

Get updates on products and services as we launch them!!!

QUALITY GUARANTEED

Get in Touch

drop us a Message

or try to find it on our website

Cilo Cybin Logo

Pre Order Registration

Register here in order to be the first to receive access to pre order products.